TBPH Short-Term Debt
Theravance Biopharma Inc · Short-Term Debt
TBPH Short-Term Debt
Latest reported$10.95Mperiod ending
TBPH FY Short-Term Debt ($69.00K → $10.95M)
Annual short-term debt
High-resolution chart · PNG
TBPH short-term debt history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Short-Term Debt (USD) |
|---|---|
| 10,945,000 | |
| 10,712,000 | |
| 3,923,000 | |
| 6,753,000 | |
| 17,443,000 | |
| 29,201,000 | |
| 17,613,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 69,000 |